BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han X, Vesely MD, Yang W, Sanmamed MF, Badri T, Alawa J, López-Giráldez F, Gaule P, Lee SW, Zhang JP, Nie X, Nassar A, Boto A, Flies DB, Zheng L, Kim TK, Moeckel GW, McNiff JM, Chen L. PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus. Sci Transl Med 2019;11:eaax1159. [PMID: 31826980 DOI: 10.1126/scitranslmed.aax1159] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Estadt SN, Maz MP, Musai J, Kahlenberg JM. Mechanisms of Photosensitivity in Autoimmunity. J Invest Dermatol 2021:S0022-202X(21)01299-9. [PMID: 34167786 DOI: 10.1016/j.jid.2021.05.007] [Reference Citation Analysis]
2 Thakkar D, Paliwal S, Dharmadhikari B, Guan S, Liu L, Kar S, Tulsian NK, Gruber JJ, DiMascio L, Paszkiewicz KH, Ingram PJ, D Boyd-Kirkup J. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner. J Immunother Cancer 2022;10:e003382. [PMID: 35131861 DOI: 10.1136/jitc-2021-003382] [Reference Citation Analysis]
3 Brown C, Rudensky AY. Enforcing T cell innocence. Science 2020;367:247-8. [PMID: 31949067 DOI: 10.1126/science.aaz7741] [Reference Citation Analysis]
4 Gray CC, Biron-girard B, Wakeley ME, Chung C, Chen Y, Quiles-ramirez Y, Tolbert JD, Ayala A. Negative Immune Checkpoint Protein, VISTA, Regulates the CD4+ Treg Population During Sepsis Progression to Promote Acute Sepsis Recovery and Survival. Front Immunol 2022;13:861670. [DOI: 10.3389/fimmu.2022.861670] [Reference Citation Analysis]
5 Rosetti F, Madera-Salcedo IK, Rodríguez-Rodríguez N, Crispín JC. Regulation of activated T cell survival in rheumatic autoimmune diseases. Nat Rev Rheumatol 2022. [PMID: 35075294 DOI: 10.1038/s41584-021-00741-9] [Reference Citation Analysis]
6 Greisen SR, Deleuran B. Checkpoint Molecules in Rheumatology-or the Benefits of Being Exhausted. Curr Rheumatol Rep 2021;23:22. [PMID: 33651184 DOI: 10.1007/s11926-021-00991-2] [Reference Citation Analysis]
7 Poon MTC, Sudlow CLM, Figueroa JD, Brennan PM. Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis. Sci Rep 2020;10:11622. [PMID: 32669604 DOI: 10.1038/s41598-020-68011-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
8 ElTanbouly MA, Schaafsma E, Smits NC, Shah P, Cheng C, Burns C, Blazar BR, Noelle RJ, Mabaera R. VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways. Front Immunol 2020;11:580187. [PMID: 33178206 DOI: 10.3389/fimmu.2020.580187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Shibru B, Fey K, Fricke S, Blaudszun AR, Fürst F, Weise M, Seiffert S, Weyh MK, Köhl U, Sack U, Boldt A. Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry. Front Immunol 2021;12:694055. [PMID: 34276685 DOI: 10.3389/fimmu.2021.694055] [Reference Citation Analysis]
10 Rogers BM, Smith L, Dezso Z, Shi X, DiGiammarino E, Nguyen D, Sethuraman S, Zheng P, Choi D, Zhang D, Nguyen A, McGuire K, Liu W, Chung N, Chao DT, Ye S, Starbeck-Miller GR. VISTA is an activating receptor in human monocytes. J Exp Med 2021;218:e20201601. [PMID: 34106206 DOI: 10.1084/jem.20201601] [Reference Citation Analysis]
11 Maz MP, Michelle Kahlenberg J. Cutaneous and systemic connections in lupus. Curr Opin Rheumatol 2020;32:583-9. [PMID: 32826479 DOI: 10.1097/BOR.0000000000000739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Alemohammad H, Najafzadeh B, Asadzadeh Z, Baghbanzadeh A, Ghorbaninezhad F, Najafzadeh A, Safarpour H, Bernardini R, Brunetti O, Sonnessa M, Fasano R, Silvestris N, Baradaran B. The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer. Biomed Pharmacother 2021;146:112516. [PMID: 34906767 DOI: 10.1016/j.biopha.2021.112516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
13 Borggrewe M, Kooistra SM, Wesseling EM, Gierschek FL, Brummer ML, Nowak EC, Medeiros-Furquim T, Otto TA, Lee SW, Noelle RJ, Eggen BJL, Laman JD. VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology. Acta Neuropathol Commun 2021;9:91. [PMID: 34006329 DOI: 10.1186/s40478-021-01186-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pant A, Medikonda R, Lim M. Alternative Checkpoints as Targets for Immunotherapy. Curr Oncol Rep 2020;22:126. [PMID: 33141349 DOI: 10.1007/s11912-020-00983-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Fisher JL, Jones EF, Flanary VL, Williams AS, Ramsey EJ, Lasseigne BN. Considerations and challenges for sex-aware drug repurposing. Biol Sex Differ 2022;13:13. [PMID: 35337371 DOI: 10.1186/s13293-022-00420-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tao T, Bo L, Li T, Shi L, Zhang H, Ye B, Xu Y, Ma Q, Deng X, Zhang G. High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response. Mediators Inflamm 2021;2021:6650329. [PMID: 34366711 DOI: 10.1155/2021/6650329] [Reference Citation Analysis]
17 Derakhshani A, Asadzadeh Z, Baradaran B, Safarpour H, Rahmani S, Leone P, Abdoli Shadbad M, Hosseinkhani N, Ghasemigol M, Ayromlou H, Ahmadi H, Pouya S, Shojaee M, Tabrizi NJ, Miraki Feriz A, Safarzadeh E, Racanelli V. The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study. Biomedicine & Pharmacotherapy 2022;148:112725. [DOI: 10.1016/j.biopha.2022.112725] [Reference Citation Analysis]
18 Wang G, Tai R, Wu Y, Yang S, Wang J, Yu X, Lei L, Shan Z, Li N. The expression and immunoregulation of immune checkpoint molecule VISTA in autoimmune diseases and cancers. Cytokine & Growth Factor Reviews 2020;52:1-14. [DOI: 10.1016/j.cytogfr.2020.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Borggrewe M, Kooistra SM, Noelle RJ, Eggen BJL, Laman JD. Exploring the VISTA of microglia: immune checkpoints in CNS inflammation. J Mol Med (Berl) 2020;98:1415-30. [PMID: 32856125 DOI: 10.1007/s00109-020-01968-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Ma YV, Sparkes A, Romão E, Saha S, Gariépy J. Agonistic nanobodies and antibodies to human VISTA. MAbs 2021;13:2003281. [PMID: 34818120 DOI: 10.1080/19420862.2021.2003281] [Reference Citation Analysis]
21 Cai X, Zhan H, Ye Y, Yang J, Zhang M, Li J, Zhuang Y. Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases. Front Genet 2021;12:785153. [DOI: 10.3389/fgene.2021.785153] [Reference Citation Analysis]
22 Nakabo S, Romo-Tena J, Kaplan MJ. Neutrophils as Drivers of Immune Dysregulation in Autoimmune Diseases with Skin Manifestations. J Invest Dermatol 2021:S0022-202X(21)01225-2. [PMID: 34253374 DOI: 10.1016/j.jid.2021.04.014] [Reference Citation Analysis]
23 Zhou S, Li Q, Zhou S, Zhao M, Lu L, Wu H, Lu Q. A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells. J Autoimmun 2021;123:102686. [PMID: 34325305 DOI: 10.1016/j.jaut.2021.102686] [Reference Citation Analysis]
24 Kahlenberg JM. Rethinking the Pathogenesis of Cutaneous Lupus. J Invest Dermatol 2021;141:32-5. [PMID: 32605817 DOI: 10.1016/j.jid.2020.05.077] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hile GA, Kahlenberg JM. Immunopathogenesis of skin injury in systemic lupus erythematosus. Curr Opin Rheumatol 2021;33:173-80. [PMID: 33315653 DOI: 10.1097/BOR.0000000000000770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Mi L, Li YC, Sun MR, Zhang PL, Li Y, Yang H. A systematic review of pharmacological activities, toxicological mechanisms and pharmacokinetic studies on Aconitum alkaloids. Chin J Nat Med 2021;19:505-20. [PMID: 34247774 DOI: 10.1016/S1875-5364(21)60050-X] [Reference Citation Analysis]
27 Dolatkhah K, Alizadeh N, Mohajjel-Shoja H, Abdoli Shadbad M, Hajiasgharzadeh K, Aghebati-Maleki L, Baghbanzadeh A, Hosseinkhani N, Karim Ahangar N, Baradaran B. B7 immune checkpoint family members as putative therapeutics in autoimmune disease: An updated overview. Int J Rheum Dis 2022. [PMID: 34994525 DOI: 10.1111/1756-185X.14273] [Reference Citation Analysis]
28 Habib A, Pease M, Kodavali CV, Amankulor N, Zinn PO. A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care. J Neurooncol 2021;151:103-12. [PMID: 33394264 DOI: 10.1007/s11060-020-03671-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 ElTanbouly MA, Schaafsma E, Noelle RJ, Lines JL. VISTA: Coming of age as a multi-lineage immune checkpoint. Clin Exp Immunol 2020;200:120-30. [PMID: 31930484 DOI: 10.1111/cei.13415] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
30 Mohammadzadeh A. Co-inhibitory receptors, transcription factors and tolerance. International Immunopharmacology 2020;84:106572. [DOI: 10.1016/j.intimp.2020.106572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yuan L, Tatineni J, Mahoney KM, Freeman GJ. VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy. Trends Immunol 2021;42:209-27. [PMID: 33495077 DOI: 10.1016/j.it.2020.12.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Yang N, Chen Z, Zhang X, Shi Y. Novel Targeted Biological Agents for the Treatment of Atopic Dermatitis. BioDrugs 2021;35:401-15. [PMID: 34213742 DOI: 10.1007/s40259-021-00490-x] [Reference Citation Analysis]
33 Lee J, Kay K, Troike K, Ahluwalia MS, Lathia JD. Sex Differences in Glioblastoma Immunotherapy Response. Neuromolecular Med 2021. [PMID: 33864598 DOI: 10.1007/s12017-021-08659-x] [Reference Citation Analysis]
34 Qie C, Jiang J, Liu W, Hu X, Chen W, Xie X, Liu J. Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir-/- murine psoriasis. Theranostics 2020;10:10483-97. [PMID: 32929361 DOI: 10.7150/thno.45614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
35 Carballido JM, Regairaz C, Rauld C, Raad L, Picard D, Kammüller M. The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases. Front Immunol 2020;11:472. [PMID: 32296421 DOI: 10.3389/fimmu.2020.00472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
36 Hosseinkhani N, Derakhshani A, Shadbad MA, Argentiero A, Racanelli V, Kazemi T, Mokhtarzadeh A, Brunetti O, Silvestris N, Baradaran B. The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead. Front Immunol 2021;12:676181. [PMID: 34093577 DOI: 10.3389/fimmu.2021.676181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Yang F, Zhang Y, Chen Z, Zhang L. VISTA Blockade Aggravates Bone Loss in Experimental Murine Apical Periodontitis. Front Immunol 2021;12:738586. [PMID: 34691045 DOI: 10.3389/fimmu.2021.738586] [Reference Citation Analysis]
38 ElTanbouly MA, Zhao Y, Schaafsma E, Burns CM, Mabaera R, Cheng C, Noelle RJ. VISTA: A Target to Manage the Innate Cytokine Storm. Front Immunol 2020;11:595950. [PMID: 33643285 DOI: 10.3389/fimmu.2020.595950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Luo S, Long H, Lu Q. Recent advances in understanding pathogenesis and therapeutic strategies of Systemic Lupus Erythematosus. Int Immunopharmacol 2020;89:107028. [PMID: 33039962 DOI: 10.1016/j.intimp.2020.107028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]